- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00169325
Clinical, Neurophysiological and Radiological Evaluation of Patients With Basal Ganglia Lesions
September 11, 2015 updated by: Marie-laure Welter
Basal ganglia are involved in the control of motor, cognitive and emotional behaviours.
The aim of this study is to precisely evaluate patients with basal ganglia focal lesions both with or without loss of psychic-self activation.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
11
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Paris, France
- Centre d'Investigation Clinique-Hôpital Pitié-Salpetriere
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with lesion of the basal ganglia structures
Description
Inclusion Criteria:
- Basal ganglia lesions
Exclusion Criteria:
- Contraindication to magnetic resonance imaging (MRI)
- Dementia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Bruno Dubois, MD, PhD, Groupe Hospitalier Pitie-Salpetriere
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
September 1, 2005
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
January 1, 2014
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 12, 2005
First Posted (Estimate)
September 15, 2005
Study Record Updates
Last Update Posted (Estimate)
September 14, 2015
Last Update Submitted That Met QC Criteria
September 11, 2015
Last Verified
September 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P031201
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Basal Ganglia Lesions
-
Assiut UniversityNot yet recruitingBasal Ganglionic Hemorrhage
-
Second Affiliated Hospital, School of Medicine,...Ningbo Medical Center Lihuili Hospital; Second Affiliated Hospital of Wenzhou... and other collaboratorsRecruitingSterotactic Operation Integrating With Thrombolysis in Basal Ganglion Hemorrhage Evacuation (SOITBE)Basal Ganglia HaematomaChina
-
Second Affiliated Hospital, School of Medicine,...First Affiliated Hospital of Fujian Medical University; Taizhou Hospital; The... and other collaboratorsRecruitingBasal Ganglia HematomaChina
-
Tel-Aviv Sourasky Medical CenterUnknownWhite Matter Lesions | Postural Instability Gait DisordersIsrael
-
Clearmind Biomedical Inc.Chang Gung Memorial HospitalCompletedCerebral Hemorrhage | Intracerebral Hemorrhage | Basal Ganglia Hemorrhage | Intracranial HemorrhageTaiwan
-
Peking University Third HospitalRecruitingBasal Ganglia HemorrhageChina
-
Second Affiliated Hospital, School of Medicine,...The First Affiliated Hospital of Anhui Medical University; Huashan Hospital; China-Japan... and other collaboratorsNot yet recruiting
-
Cynosure, Inc.CompletedBenign Pigmented Lesions | Wrinkle | Benign Vascular LesionsUnited States
-
Rigshospitalet, DenmarkCompletedFocal Liver Lesions | Focal Lesions in the AbdomenDenmark
-
Orthopaedic Research FoundationGenzyme, a Sanofi CompanyCompletedChondrosis | Patellar Articular Cartilage Lesions | Trochlear Articular Cartilage LesionsUnited States
Clinical Trials on Magnetic resonance imaging
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingProstate Adenocarcinoma | Prostate CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Recruiting
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityRecruitingIntracranial NeoplasmUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Healthy SubjectUnited States
-
Stanford UniversityTerminatedLaryngeal Neoplasms | Head and Neck Cancers | Larynx CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedBrain TumorUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedThoracic Spine NeoplasmUnited States
-
University of California, San FranciscoTerminatedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditionsUnited States